Form 4: Astera Labs General Counsel Philip Mazzara Sells Shares Under 10b5-1 Trading Plan
SEC Form 4
Philip Mazzara, General Counsel and Secretary of Astera Labs, Inc. (ALAB), sold shares of common stock on November 7 and 8, 2024, under a pre-arranged Rule 10b5-1 trading plan.
Summary
- Philip Mazzara, General Counsel and Secretary of Astera Labs, Inc., filed a Form 4 disclosing changes in beneficial ownership.
- On November 7 and 8, 2024, Mazzara sold shares of Astera Labs common stock.
- The sales were executed under a Rule 10b5-1 trading plan adopted on May 24, 2024.
- The transactions involved multiple sales at varying prices, ranging from approximately $93.43 to $99.79 per share.
- Following the reported transactions, Mazzara directly owns 250,564 shares of Astera Labs common stock.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing related to insider trading. It doesn't inherently convey positive or negative sentiment, as it simply reports transactions.
Industry Context
This filing is a routine disclosure of insider trading activity. It is common for executives to use 10b5-1 plans to sell shares over time to avoid accusations of trading on inside information.
Stakeholder Impact
- The stock sales by a company insider could be perceived negatively by some shareholders, potentially leading to slight downward pressure on the stock price.
Key Dates
| Date | Description |
|---|---|
| May 24, 2024 | Date the Reporting Person adopted a Rule 10b5-1 trading plan |
| November 07, 2024 | Date of first reported transaction |
| November 08, 2024 | Date of last reported transaction |
| November 12, 2024 | Date of Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.